#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    T-cell lymphoma Pancreatic neuroendocrine tumour Cystic fibrosis gastrointestinal disease Lung adenocarcinoma Cryoglobulinaemia Hormone-dependent prostate cancer Neovascular age-related macular degeneration Chemical burn Pulmonary fibrosis Friedreich's ataxia Acquired ATTR amyloidosis Pustular psoriasis Fibrosarcoma Skin angiosarcoma Adenomatous polyposis coli More trials…

    Learn about Rare Diseases

    Hairy cell leukaemia Malignant fibrous histiocytoma – Diagnostics Haemophagocytic lymphohistiocytosis – Life with Disease Gaucher’s disease type I – Diagnostics Chronic granulomatous disease – Life with Disease Vascular malformation – Diagnostics Hepatoblastoma – Trials in Disease Paroxysmal nocturnal haemoglobinuria – Basic Information Mantle cell lymphoma stage IV – Diagnostics Mucous membrane pemphigoid – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Inebilizumab Bi 685509 Belantamab Mafodotin Clindamycin Phosphate Iclepertin Trandolapril Morphine Hydrochloride Quetiapine Lisinopril Dihydrate Cyclophosphamide Ag-946 Ibuprofen Sodium Dihydrate Other Blood Products Human Mesenchymal Stem Cells Dl-Alpha-Tocopherol VANADIUM OXIDE SULFATE Dabigatran Etexilate Sacituzumab Govitecan Povidone, Iodinated Liraglutide More therapies…

    Learn about Your Condition

    Raynaud's phenomenon Hyperkalaemia Fontan procedure Coma Familial mediterranean fever Measles Atrial flutter C3 glomerulopathy Liposarcoma metastatic Gastric cancer Epicondylitis K-ras gene mutation Haemolytic uraemic syndrome Thrombosis prophylaxis Tumour of ampulla of Vater More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Multiprofile Hospital For Active Treatment…

University Multiprofile Hospital For Active Treatment Saint Georgi EAD

Bomxqfuu Pltazsunjl Ssdre 6vi Puavsetj 4ajqs Brftvurl

Want to learn more about this study or check if you can participate? Contact us.

  • Efficacy, Safety, and Tolerability of NBI-1065890 in Adults with Tardive Dyskinesia

    Recruiting

    2 1
    Investigated Diseases:
    • Tardive dyskinesia
    Bulgaria Croatia Czechia Romania Slovakia

  • Phase 3 Randomized Placebo‑Controlled Study of Efgartigimod Alfa in Adults with Graves’ Disease Inadequately Controlled by Antithyroid Drugs

    Recruiting

    3 1 1
    Investigated Diseases:
    • Graves’ disease
    Investigated Drugs:
    • Efgartigimod Alfa
    Belgium Bulgaria Czechia Denmark France Germany +8

  • Study on the Effectiveness of Concizumab for Children Under 12 with Hemophilia A or B, With or Without Inhibitors

    Recruiting

    3 1 1
    Investigated Diseases:
    • Haemophilia B without inhibitors
    • Haemophilia A without inhibitors
    • Factor IX deficiency
    Investigated Drugs:
    • Concizumab
    Bulgaria France Greece Italy Lithuania Norway +4

  • Efficacy and Safety of BAY 3670549 in Adults with Atrial Fibrillation: A Randomized, Double‑Blind, Placebo‑Controlled Phase 2 Study

    Recruiting

    2 1
    Belgium Bulgaria Germany Hungary Italy The Netherlands +1

  • Phase IIb Study of AZD8965 versus Placebo in Adults with Idiopathic Pulmonary Fibrosis

    Recruiting

    2 1
    Bulgaria Denmark France Germany Greece Hungary +4

  • Phase 2 Study of Nemolizumab for Skin Thickening in Adults with Systemic Sclerosis

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Nemolizumab
    Bulgaria Croatia France Greece Italy Poland +1

  • Zenagamtide Compared with Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes

    Recruiting

    3 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    • Obesity
    • Overweight
    Investigated Drugs:
    • Semaglutide
    Bulgaria Croatia Germany Hungary Poland Portugal +1

  • Long-Term Study of Imeroprubart in Adults With Graves’ Disease

    Recruiting

    2 1 1
    Investigated Drugs:
    • IMEROPRUBART
    Belgium Bulgaria Czechia Germany Greece Hungary +5

  • Study of KAI-9531 in Adults With Obesity or Overweight and Weight-Related Health Problems Without Diabetes

    Recruiting

    3 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • HRS 9531
    Bulgaria Czechia Germany Hungary Poland Spain

  • KAI-9531 in Adults With Obesity or Overweight and Diabetes

    Recruiting

    3 1
    Investigated Drugs:
    • HRS 9531
    Bulgaria Czechia Germany Hungary Poland Spain
1 2 3 … 20
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!